Congratulations! Your deal navigated through antitrust review, you closed the transaction, and you are making your way through the three-year integration plan. The target’s corporate office was closed, you have transitioned the back- office functions to your personnel and systems, and you have consolidated product lines. Concerns about antitrust risk are long past. “Not so fast,” says one federal court.
Previous article US MERGER CONTROL IN THE PHARMACEUTICAL SECTOR Next article An Examination of Global Class Action Regimes after Godfrey